|
|
||||||||
Ann Thorac Surg 2000;70:1515-1520
© 2000 The Society of Thoracic Surgeons
a Department of Anesthesiology, Childrens Hospital of Wisconsin and Medical College of Wisconsin, Milwaukee, Wisconsin, USA
b Department of Pediatric Critical Care Medicine, Childrens Hospital of Wisconsin and Medical College of Wisconsin, Milwaukee, Wisconsin, USA
c Department of Pediatric Cardiology, Childrens Hospital of Wisconsin and Medical College of Wisconsin, Milwaukee, Wisconsin, USA
d Department of Cardiovascular Surgery, Childrens Hospital of Wisconsin and Medical College of Wisconsin, Milwaukee, Wisconsin, USA
Address reprint requests to Dr Hoffman, Department of Pediatric Anesthesiology and Critical Care Medicine, Childrens Hospital of Wisconsin #735, 9000 West Wisconsin Ave, Milwaukee, WI 53226
e-mail: ghoffman{at}mcw.edu
Presented at the Thirty-sixth Annual Meeting of The Society of Thoracic Surgeons, Fort Lauderdale, FL, Jan 31Feb 2, 2000.
| Abstract |
|---|
|
|
|---|
Methods. A prospective perioperative database was maintained for demographic, hemodynamic, and laboratory data. Invasive arterial and atrial pressures, arterial saturation, oximetric superior vena cava (SVC) saturation, and end-tidal CO2 were continuously recorded and logged hourly for the first 48 postoperative hours. Arterial and venous blood gases and cooximetry were obtained at clinically appropriate intervals. SVC saturation was used as an approximation of mixed venous saturation (SvO2). A standard base excess (BE) less than -4 mEq/L (BElo), or a change exceeding -2 mEq/L/h (
BElo), were used as indicators of anaerobic metabolism. The relationship between SvO2 and BE was tested by analysis of variance and covariance for repeated measures; the binomial risk of BElo or
BElo at SvO2 strata was tested by the likelihood ratio test and logistic regression, with cutoff at p < 0.05.
Results. Complete data were available in 48 of 51 consecutive patients undergoing NP yielding 2,074 valid separate determinations. BE was strongly related to SvO2 (model R2 = 0.40, p < 0.0001) with minimal change after adjustment for physiologic covariates. The risk of anaerobic metabolism was 4.8% overall, but rose to 29% when SvO2 was 30% or below (p < 0.0001). Survival was 100% at 1 week and 94% at hospital discharge.
Conclusions. Analysis of acid-base changes revealed an apparent anaerobic threshold when SvO2 fell below 30%. Clinical management to maintain SvO2 above this threshold yielded low mortality.
| Introduction |
|---|
|
|
|---|
| Material and methods |
|---|
|
|
|---|
Postoperative management targets included mean arterial blood pressure (MABP) greater than 45 mm Hg, SvO2 greater than 50%, SaO2 70% to 80%, and clinical evidence of end-organ function. All patients received continuous fentanyl infusions at 5 to 10 µg/kg/h, and neuromuscular blockade was maintained by vecuronium infusion until postoperative day 1. Patients were maintained at normothermia in servo-controlled infant warmers (Ohio Infant Warmer System; Ohmeda Inc, Columbia, MD). Ventilator settings were adjusted to maintain arterial normocapnia (PaCO2 35 to 45 torr) with the lowest FiO2 that did not reduce SaO2 or SvO2. Pulmonary-to-systemic flow ratio (Qp/Qs) was calculated from SaO2 and SvO2 using an assumed pulmonary capillary saturation of 97% [1, 3, 4]. Low SvO2 with high Qp/Qs was addressed by attempts to lower SVR with additional analgesia or sedation, nitroprusside, or initiation of phenoxybenzamine infusion. Low SvO2 with balanced Qp/Qs was addressed by transfusion of red cells to achieve a hematocrit in the 45% to 50% range, and increased inotropic support when necessary.
Arterial blood gases were obtained hourly for the first 4 postoperative hours, and then at intervals dependent upon patient condition. The standard base excess, calculated without temperature correction, was used to identify metabolic acidosis. Persistent or worsening metabolic acidosis not explainable by electrolyte abnormalities was interpreted as evidence of systemic hypoperfusion [6], and interventions to increase systemic oxygen delivery were initiated. Treatment with buffer (NaHCO3 1 mEq/kg) was reserved for worsening metabolic acidosis after interventions to optimize circulation, and was administered in 11 instances. Circulatory support with extracorporeal membrane oxygenation (ECMO) was initiated in 1 patient with persistent metabolic acidosis and profound venous desaturation at the seventh postoperative hour.
Monitoring and data collection
A prospective perioperative database for all patients undergoing the Norwood repair of HLHS since July 1996 was maintained for demographic, surgical, and 48-hour postoperative hemodynamic and laboratory data. Physiologic parameters included invasive arterial (MABP) and atrial pressures (RAP), arterial saturation (N-200; Nellcor, Haywood, CA), inspired oxygen and end-tidal carbon dioxide tension, and SvO2 as an approximation of mixed venous saturation [7, 8]. These parameters were continuously displayed, digitally acquired, and averaged using either a dedicated PC-based monitoring cart (DAP-102; Microstar Labs, Belleview, WA; and DasyLab; DasyTec GmBH, Concord, NH) or a multichannel clinical information system (Solar 3000; Marquette Electronics, Milwaukee, WI). Arterial and venous blood gases and cooximetry (ABL; Radiometer, Copenhagen, Denmark) were obtained at clinically appropriate intervals. The physiologic parameters, laboratory data, ventilator parameters, and medication infusion rates were recorded hourly for the first 48 postoperative hours using a standardized, prospective format.
From measurements of SaO2, SvO2, MABP, RAP, and hemoglobin concentration, hemodynamic and oxygen transport indices were derived according to standard formulae, assuming pulmonary capillary saturation of 97% and oxygen consumption of 160 mL/min/m2 [1, 3, 4, 9]. These derived parameters included arteriovenous O2 difference in saturation (
Sa-vO2) and content (
Ca-vO2), oxygen extraction ratio (O2ER), pulmonary blood flow (Qp), systemic blood flow (Qs), pulmonary/systemic flow ratio (Qp/Qs), systemic vascular resistance index (SVRI), and total pulmonary vascular resistance index (PVRI).
Statistical analysis
Data were summarized as mean ± standard deviation (SD) when continuous, or number and percent when discrete, unless otherwise specified. Blood gas data were subjected to linear interpolation between determinations, and excluded from analysis if coincident with buffer administration. Oximetric data were excluded when the arterial venous saturation difference was less than 8%, or during ECMO support. Anaerobic conditions were defined by a standard base excess (BE) less than -4 mEq/L (BElo), or a change exceeding -2 mEq/L/h (
BElo) [6, 1012]. Differences in physiologic data between anaerobic and aerobic conditions were tested by one-way analysis of variance (ANOVA), and z scores for these statistics at anaerobic conditions were computed. After creation of equal-width strata from continuous variables, relationships were tested by quantile (median) regression, categorical ANOVA with post-hoc contrasts by the Tukey WSD method, and the likelihood ratio test for proportions. Anaerobic risk across the range of SvO2 was predicted by logistic regression. Risk estimates were calculated with and without adjustment for covariates that had univariate relation to anaerobic indicators. All statistical calculations were performed with correction for repeated measures, and with significance cutoff at p < 0.05 after correction for multiple comparisons, using a standard statistical package (Stata Statistical Software, Release 6; StataCorp, College Station, TX).
| Results |
|---|
|
|
|---|
|
BE) of <-2 mEq/L/h (
BElo) corresponded to 2.56 SD below the mean
BE of 0.10 ± 0.82 mEq/L/h, and was present in 34 patient hours (1.6% of time). Either indicator of anaerobic conditions was detected for 102 patient hours or 4.8% of time overall, 9.1% of time during hours 1 to 24, and 0.5% of time during hours 25 to 48. Anaerobic indicators were present for 9.3% of time with SvO2 below 50%, and 2.8% of time with SvO2 at or above 50%, for an adjusted odds ratio of 3.33 (p < 0.001 by likelihood ratio test). A summary of hemodynamic, respiratory, acid-base, and support modalities appears in Table 2. Physiologic parameters with greater changes at anaerobic conditions are indicated by high z scores and significance tests by ANOVA. No significant differences in SaO2, SVRI, PVRI, PaO2, or PaCO2 occurred with anaerobic conditions. The highest anaerobic z score (-0.71) occurred for SvO2.
|
|
|
|
|
|
| Comment |
|---|
|
|
|---|
The concept of anaerobic threshold implies alteration of cellular metabolism from oxygen supply limitation, usually associated with metabolic acidosis and increased lactate production [13, 14]. Although we did not routinely measure lactate in this study, the appearance of lactate, pyruvate, or other strong acids as products of anaerobic metabolism will reduce the base excess stoichiometrically [6, 10, 11, 15]. The fall in BE may exceed the rise in lactate because of the production of other anions under anaerobic conditions [6, 12]. Similarly, the BE may fall during splanchnic hypoperfusion from the failure of hepatic and renal clearance of anions [16] which are substrates for intermediary metabolism without increased production of lactate. Conversely, in experimental cardiogenic shock, the rise in lactate in venous blood may indicate reperfusion after critical hypoperfusion [17, 18]. Thus, the presence or development of a significant metabolic acidosis (BElo or
BElo) in a patient population with an overall increasing metabolic alkalosis (mean BE 3.8 mEq/L; mean
BE + 0.1 mEq/L/h) will indicate a significantly altered metabolic state as a result of critical organ hypoperfusion.
Some physiologic variables included in this analysis have been derived using assumptions that must be emphasized. In this patient population, no single blood sample can represent mixed venous blood. Although inferior vena cava sampling should be more sensitive to splanchnic hypoperfusion [19], repeated measurements are more variable because of blood streaming. Assumed values for VO2 and pulmonary venous saturation may characterize the study population more accurately than individuals within it. Despite these limitations, these parameters are commonly used to characterize pulmonary and systemic hemodynamics [13, 7, 8, 20, 21].
Direct treatment of metabolic acidosis with buffer, although infrequent, was more likely to occur in patients with acid-base abnormalities that would fit our definition of anaerobic conditions. The relationship between SvO2 and anaerobic indicators was actually stronger without exclusion of these data points, because our correction of metabolic acidosis was rarely complete. However, we chose to exclude them because such treatment altered the relationship under study.
SvO2 monitoring can reveal deterioration in oxygen transport and guide treatment before supplydependent conditions develop [14]. Other investigations have revealed an apparent anaerobic threshold at a SvO2 of 15% to 25% in neonatal piglets subject to hypoxic hypoxia, and higher in anemic hypoxia [10, 2224]. The relationship between oxygen transport and utilization is probably less predictable in distributive shock [25], and 2 patients in our series did have persistent biochemical evidence of anaerobic metabolism at high SvO2, but maldistribution is not the predominant pathophysiologic mechanism in the early postoperative course in this patient population. Examination of Table 2 reveals that the predominant hemodynamic abnormality in our patients was low total cardiac output (more precisely, low oxygen supply/demand relationship) with relatively balanced Qp/Qs. SvO2 monitoring can reveal changes in oxygen supply/demand relationships even under supply-dependent conditions [24], and our data support its use in prediction of pathologic cellular oxygen status in this patient population.
Low SvO2 can predict poor outcome of patients after myocardial infarction [26], adult cardiac surgery [27], and NP for HLHS [1]. Interventions to increase low SvO2 can improve outcome [4, 28, 29]. Knowledge of an approximate value for critical SvO2 can guide thresholds for intervention that target either SvO2 itself or derived parameters such as available oxygen [20, 21] before pathologic oxygen supply conditions develop.
Our management target of SvO2 greater than 50% yielded low mortality and revealed a period of physiologic risk in the first 24 postoperative hours for both low SvO2 and biochemical indication of anaerobic metabolism. The adjusted odds ratio for anaerobic metabolism was 8.0 for SvO2 less than 30% compared with higher SvO2. Because this threshold was not apparent by examination of the relationship of SaO2 or MABP to anaerobic indicators, we have concluded that SvO2 monitoring is essential to guide management strategies that avoid the risk of cellular hypoxia and resultant mortality after the NP for HLHS.
| Acknowledgments |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
Related Article
This article has been cited by other articles:
![]() |
B. A. Johnson, G. M. Hoffman, J. S. Tweddell, J. R. Cava, M. Basir, M. E. Mitchell, M. C. Scanlon, K. A. Mussatto, and N. S. Ghanayem Near-infrared spectroscopy in neonates before palliation of hypoplastic left heart syndrome. Ann. Thorac. Surg., February 1, 2009; 87(2): 571 - 579. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, G. Zhang, H. Holtby, S. Cai, M. Walsh, C. A. Caldarone, and G. S. Van Arsdell Significant correlation of comprehensive Aristotle score with total cardiac output during the early postoperative period after the Norwood procedure J. Thorac. Cardiovasc. Surg., July 1, 2008; 136(1): 123 - 128. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. J. Liakopoulos, J. K. Ho, A. Yezbick, E. Sanchez, C. Naddell, G. D. Buckberg, R. Crowley, and A. Mahajan An Experimental and Clinical Evaluation of a Novel Central Venous Catheter with Integrated Oximetry for Pediatric Patients Undergoing Cardiac Surgery Anesth. Analg., December 1, 2007; 105(6): 1598 - 1604. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Tweddell, N. S. Ghanayem, K. A. Mussatto, M. E. Mitchell, L. J. Lamers, N. L. Musa, S. Berger, S. B. Litwin, and G. M. Hoffman Mixed Venous Oxygen Saturation Monitoring After Stage 1 Palliation for Hypoplastic Left Heart Syndrome Ann. Thorac. Surg., October 1, 2007; 84(4): 1301 - 1311. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Edwards, K. P Morris, A. Siddiqui, D. Harrington, D. Barron, and W. Brawn Norwood procedure for hypoplastic left heart syndrome: BT shunt or RV-PA conduit? Arch. Dis. Child. Fetal Neonatal Ed., May 1, 2007; 92(3): F210 - F214. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sano New Era in Management of Hypoplastic Left Heart Syndrome Asian Cardiovasc Thorac Ann, April 1, 2007; 15(2): 83 - 85. [Full Text] [PDF] |
||||
![]() |
J. Li, G. Zhang, B. W. McCrindle, H. Holtby, T. Humpl, S. Cai, C. A. Caldarone, A. N. Redington, and G. S. Van Arsdell Profiles of hemodynamics and oxygen transport derived by using continuous measured oxygen consumption after the Norwood procedure J. Thorac. Cardiovasc. Surg., February 1, 2007; 133(2): 441 - 448. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Ghanayem, R. D.B. Jaquiss, J. R. Cava, P. C. Frommelt, K. A. Mussatto, G. M. Hoffman, and J. S. Tweddell Right Ventricle-to-Pulmonary Artery Conduit Versus Blalock-Taussig Shunt: A Hemodynamic Comparison Ann. Thorac. Surg., November 1, 2006; 82(5): 1603 - 1610. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Li, G S Van Arsdell, G Zhang, S Cai, T Humpl, C A Caldarone, H Holtby, and A N Redington Assessment of the relationship between cerebral and splanchnic oxygen saturations measured by near-infrared spectroscopy and direct measurements of systemic haemodynamic variables and oxygen transport after the Norwood procedure Heart, November 1, 2006; 92(11): 1678 - 1685. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, G. Zhang, H. M. Holtby, B. W. McCrindle, S. Cai, T. Humpl, C. A. Caldarone, W. G. Williams, A. N. Redington, and G. S. Van Arsdell Inclusion of oxygen consumption improves the accuracy of arterial and venous oxygen saturation interpretation after the Norwood procedure J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 1099 - 1107. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Andersen and C. L. Collins Poor Circulation, Early Brain Injury, and the Potential Role of Red Cell Transfusion in Premature Newborns Pediatrics, April 1, 2006; 117(4): 1464 - 1466. [Full Text] [PDF] |
||||
![]() |
M. Ricci, P. Lombardi, A. Galindo, A. Vasquez, J. Zuccarelli, and E. Rosenkranz Distribution of cardiac output and oxygen delivery in an acute animal model of single-ventricle physiology J. Thorac. Cardiovasc. Surg., October 1, 2005; 130(4): 1062 - 1070. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Hoffman, K. A. Mussatto, C. L. Brosig, N. S. Ghanayem, N. Musa, R. T. Fedderly, R. D.B. Jaquiss, and J. S. Tweddell Systemic venous oxygen saturation after the Norwood procedure and childhood neurodevelopmental outcome J. Thorac. Cardiovasc. Surg., October 1, 2005; 130(4): 1094 - 1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Rumball, S. P. McGuirk, O. Stumper, S. J. Laker, J. V. de Giovanni, J. G. Wright, D. J. Barron, and W. J. Brawn The RV-PA conduit stimulates better growth of the pulmonary arteries in hypoplastic left heart syndrome Eur. J. Cardiothorac. Surg., May 1, 2005; 27(5): 801 - 806. [Abstract] [Full Text] [PDF] |
||||
![]() |
U Theilen and L Shekerdemian The intensive care of infants with hypoplastic left heart syndrome Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2005; 90(2): F97 - F102. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Soetenga and K. A. Mussatto Management of Infants With Hypoplastic Left Heart Syndrome: Integrating Research Into Nursing Practice Crit. Care Nurse, December 1, 2004; 24(6): 46 - 66. [Full Text] [PDF] |
||||
![]() |
S. Sano, K. Ishino, H. Kado, Y. Shiokawa, K. Sakamoto, M. Yokota, and M. Kawada Outcome of Right Ventricle-to-Pulmonary Artery Shunt in First-Stage Palliation of Hypoplastic Left Heart Syndrome: A Multi-Institutional Study Ann. Thorac. Surg., December 1, 2004; 78(6): 1951 - 1958. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tanoue, H. Kado, Y. Shiokawa, N. Fusazaki, and S. Ishikawa Midterm Ventricular Performance After Norwood Procedure With Right Ventricular-Pulmonary Artery Conduit Ann. Thorac. Surg., December 1, 2004; 78(6): 1965 - 1971. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Hoffman, J. S. Tweddell, N. S. Ghanayem, K. A. Mussatto, E. A. Stuth, R. D. B. Jaquis, and S. Berger Alteration of the critical arteriovenous oxygen saturation relationship by sustained afterload reduction after the norwood procedure J. Thorac. Cardiovasc. Surg., March 1, 2004; 127(3): 738 - 745. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Checchia, R. Larsen, R. Sehra, N. Daher, S. R. Gundry, A. J. Razzouk, and L. L. Bailey Effect of a selection and postoperative care protocol on survival of infants with hypoplastic left heart syndrome Ann. Thorac. Surg., February 1, 2004; 77(2): 477 - 483. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Bradley, A. M. Atz, and J. M. Simsic Redefining the impact of oxygen and hyperventilation after the Norwood procedure J. Thorac. Cardiovasc. Surg., February 1, 2004; 127(2): 473 - 480. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Ungerleider, I. Shen, T. Yeh Jr, J. Schultz, R. Butler, M. Silberbach, C. Giacomuzzi, E. Heller, L. Studenberg, B. Mejak, et al. Routine mechanical ventricular assist following the Norwood procedure--improved neurologic outcome and excellent hospital survival Ann. Thorac. Surg., January 1, 2004; 77(1): 18 - 22. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Hoffman, E. A. Stuth, R. D. Jaquiss, P. L. Vanderwal, S. R. Staudt, T. J. Troshynski, N. S. Ghanayem, and J. S. Tweddell Changes in cerebral and somatic oxygenation during stage 1 palliation of hypoplastic left heart syndrome using continuous regional cerebral perfusion J. Thorac. Cardiovasc. Surg., January 1, 2004; 127(1): 223 - 233. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sano, K. Ishino, M. Kawada, S. Arai, S. Kasahara, T. Asai, Z.-i. Masuda, M. Takeuchi, and S.-i. Ohtsuki Right ventricle-pulmonary artery shunt in first-stage palliation of hypoplastic left heart syndrome J. Thorac. Cardiovasc. Surg., August 1, 2003; 126(2): 504 - 510. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kaneko, Y. Hirata, K. Yagyu, A. Murakami, and S. Takamoto Pulmonary-to-systemic blood flow ratio oriented management after repair of obstructive total anomalous pulmonary venous connection in neonates with single ventricle Ann. Thorac. Surg., March 1, 2003; 75(3): 1010 - 1012. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Drinkwater Jr, A. S. Aharon, S. V. Quisling, D. Dodd, V. S. Reddy, A. Kavanaugh-McHugh, T. Doyle, N. R. Patel, F. E. Barr, J. K. Kambam, et al. Modified Norwood operation for hypoplastic left heart syndrome Ann. Thorac. Surg., December 1, 2001; 72(6): 2081 - 2087. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Bradley, J. M. Simsic, and A. M. Atz Hemodynamic effects of inspired carbon dioxide after the Norwood procedure Ann. Thorac. Surg., December 1, 2001; 72(6): 2088 - 2093. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tabbutt, C. Ramamoorthy, L. M. Montenegro, S. M. Durning, C. D. Kurth, J. M. Steven, R. I. Godinez, T. L. Spray, G. Wernovsky, and S. C. Nicolson Impact of Inspired Gas Mixtures on Preoperative Infants With Hypoplastic Left Heart Syndrome During Controlled Ventilation Circulation, September 18, 2001; 104 (2009): I-159 - I-164. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |